A new DDW 2025 study reveals a surprising truth: most post-polypectomy colorectal cancers are diagnosed before recommended follow-up—and many are already advanced. So, what’s driving these missed opportunities? The quality of the baseline colonoscopy is under scrutiny, with evidence pointing to missed or incompletely resected lesions and significant differences in cancer risk tied to a physician’s adenoma detection rate (ADR).
As concerns grow around patient compliance and procedural performance, could noninvasive tools like FIT help close the gap in surveillance? The case for rethinking traditional CRC monitoring is growing.